For instance, a study involving 61 patients with primary nodal DLBCL revealed higher expression of CCR7 in the non-GCB subtype compared to the GCB subtype, with its elevated expression correlating with poorer overall survival rates, thereby establishing it as an independent prognostic factor in the disease [11]. Here, CCR7 is linked to diffuse large B-cell lymphoma.